ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
THAW TUN MD

Internal Medicine

14,544

$728K

416
335 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

SATINDER DALAWARI MD

Internal Medicine

14,529

$787K

450
284 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

DANIEL HERDEMAN MD

Internal Medicine

14,339

$779K

683
558 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

TOM MARTIN MD

Internal Medicine

14,314

$772K

428
379 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

KADHIRESAN MURUGAPPAN MD SC

Internal Medicine

14,304

$571K

353
304 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$40
Average prescription price

Avg: $60

LAWRENCE JENNINGS MD

Internal Medicine

14,302

$602K

440
378 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $60

NEIL NELSON MD

Internal Medicine

14,299

$664K

363
282 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $60

LAVERNE CURRIE M.D.

Internal Medicine

14,247

$462K

654
560 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$32
Average prescription price

Avg: $60

NECHOLAS GHANNAM MD

Internal Medicine

14,241

$562K

631
540 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$39
Average prescription price

Avg: $60

PETER ROUMELIOTIS MD

Internal Medicine

14,238

$861K

439
396 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $60

JEAN SHLYAK M.D.

Internal Medicine

14,107

$728K

313
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $60

ALAN ESKER MD

Internal Medicine

14,058

$775K

561
452 are 65+

8%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $60

SUMITHA PANICKER M.D.

Internal Medicine

14,037

$765K

393
360 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $60

CICILY JONES MD

Internal Medicine

14,003

$860K

369
321 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $60

SRINIVASARAO YAGANTI M.D.

Internal Medicine

13,999

$726K

323
269 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $60

CARL JOHNSON M.D.

Internal Medicine

13,998

$752K

422
333 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

WILLIAM BOBLICK MD

Internal Medicine

13,996

$898K

620
545 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $60

NOUR KABBANI M.D.

Internal Medicine

13,993

$615K

315
266 are 65+

16%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$44
Average prescription price

Avg: $60

FELIKS MAVASHEV MD

Internal Medicine

13,973

$902K

400
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $60

RICHARD BALEY M.D.

Internal Medicine

13,958

$849K

608
571 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $60

RAMON INCIONG MD

Internal Medicine

13,945

$692K

502
440 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

15%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

SHANTALA SREERAMA M.D.

Internal Medicine

13,941

$604K

650
556 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $60

CRISANTO REYES M.D.

Internal Medicine

13,940

$774K

461
324 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

31%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$56
Average prescription price

Avg: $60

OUEDRAEGO BERNARD MD

Internal Medicine

13,927

$724K

390
205 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$52
Average prescription price

Avg: $60

BASSAM ALBARCHA MD,FACP

Internal Medicine

13,920

$859K

432
235 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank